CD276 and breast cancer: Additionally, another anti-B7-H3 drug conjugate, ITC-6102RO, was found to reduce cell viability and promote apoptosis by inducing DNA damage and causing cell cycle arrest in the S phase in lung and breast cancer cell lines [102].